The capabilities of innovator manufacturers in low cost regions are also building rapidly alongside the supply of generic products. The pressure on healthcare costs is not going to reverse: payers, providers and patients will continue to demand lower costs and greater value for the money spent.
Incremental change is no longer an option for the branded pharmaceutical sector.
To stay at the top of the sector global pharmaceutical manufacturers need to restructure more radically and much faster. We suggest that the global pharmaceutical industry could learn valuable lessons from the experiences of the automotive and electronics sectors.
To find out more about we can help pharmaceutical companies evolve, please contact us now.
PRINT
EMAIL
TWITTER
LINKEDIN
FACEBOOK
FEEDS